Jenny Murase, MD: Assessing Symptoms and Presentation of Patients with Prurigo Nodularis

December 10, 2025

Dr. Murase reviews the clinical presentation of Prurigo Nodularis, a chronic inflammatory skin condition characterized by intensely pruritic nodules and significant disease burden. She outlines common symptoms and diagnostic considerations while highlighting emerging research supporting the use of Nemolizumab as an effective treatment option.

Topics Covered

Key symptoms and clinical presentation of prurigo nodularis
The role of chronic itch in disease progression
Diagnostic considerations and patient evaluation
Evidence supporting nemolizumab in improving symptoms and lesion burden

Explore Related Resources

MORE EXPERT PERSPECTIVES IN PRURIGO NODULARIS:

Angela Lamb, MD: Breaking the Itch-Scratch Cycle in Prurigo Nodularis

Angela Lamb, MD, an associate professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses recent advancements in understanding

David Cotter, MD, PhD: Patient Presentation and Clinical Trial Data for Prurigo Nodularis

Dr. Cotter, a board-certified dermatologist at Las Vegas Dermatology, presents a real-world case of Prurigo Nodularis, highlighting both the severity of disease presentation and the

James Del Rosso, DO, and David G. Cotter, MD, PhD: Targeting the IL-31 Neuroimmune Pathway for Treating Prurigo Nodularis

Drs. Del Rosso and Cotter discuss how advances in the molecular understanding of Prurigo Nodularis have led to the development of targeted therapies that address

Diego Ruiz Dasilva, MD, FAAD: Providing Treatment for Challenging Cases of Chronic Pruritus

Dr. Dasilva presents findings from a real-world case series evaluating treatment options for patients with treatment-resistant chronic pruritus, highlighting the marked efficacy of Nemolizumab. His

JCAD Archives